Rocket Lab Raises $474M in Share Sale; Backlog Soars 69%
Rocket Lab raised gross proceeds of $474 million by selling 6.7 million shares and entered collared forward transactions on 7.5 million shares with potential proceeds up to $642 million. Backlog jumped 69% QoQ to $1.85 billion as Neutron rocket launch slipped to Q4, with shares trading at 44× forward P/S.
1. Equity Offering and Collared Forwards
Rocket Lab completed an at-the-market equity offering, selling 6.7 million shares for gross proceeds of $474 million before commissions and expenses. It also entered collared forward transactions on 7.5 million shares with minimum proceeds of $474 million and maximum proceeds of $642 million, maturing in April 2028. Net proceeds are earmarked for growth initiatives, potential acquisitions, and general corporate purposes.
2. Backlog Growth and Financial Metrics
The company’s backlog surged 69% quarter-over-quarter to $1.85 billion, driven by new customer orders for Electron and Neutron missions. This order book expansion underscores solid demand, but the stock’s 44× forward price-to-sales multiple leaves little room for execution missteps. Investors will monitor revenue recognition as launches progress.
3. Neutron Launch Delay and Execution Risks
The debut of the Neutron heavy-lift rocket has been pushed to the fourth quarter, extending development timelines and raising execution risk. Further delays or cost overruns could strain cash flow and investor confidence. Key upcoming milestones and test flight readiness will be critical for validating the refreshed growth narrative.